Persistence Capital Partners

About

Founded in 2008 by Dr. Sheldon Elman and Stuart M. Elman, Persistence Capital Partners ("PCP") is Canada’s only private equity fund exclusively focused on high-growth opportunities in Canadian healthcare.

The firm is composed of former owners, operators and regulators of healthcare businesses in Canada and around the world, with more than a hundred years of collective experience. We understand the strategic and operational issues business owners and management teams are facing. This makes PCP the partner of choice for growth capital, or to provide business owners with full or partial exit opportunities.

Our investors include leading Canadian institutional investors, Canadian financial institutions, and high net worth individuals. The Partners of PCP are also significant investors in our funds.

We believe in responsible capital stewardship; we practice transparency, timely communications and full disclosure to our investors and partners.

Source: Persistence Capital Partners

Strategy

Healthcare is all we do. Canada is the market we know.

Persistence Capital Partners’ ("PCP") investment strategy has resulted in superior returns for our investors.

We seek out investment opportunities in post-revenue and earnings, entrepreneur-driven, growth-and-service oriented healthcare businesses. We acquire private companies, support management buy-outs, provide growth capital, and lead industry consolidations and roll-ups. Our specialization affords our portfolio company partners unique opportunities to leverage one another for growth.

With a team of successful healthcare entrepreneur-operators and financial experts, PCP works actively and closely with portfolio companies in developing strategic plans to accelerate growth and profitability. We also act as a financial partner to our portfolio companies by providing strategic direction and transaction support, as with mergers, acquisitions, recapitalizations, divestitures/carve-outs, distressed restructuring, and financing.


Source: Persistence Capital Partners